Literature DB >> 10556167

CD8(+) T cell subsets and chronic obstructive pulmonary disease.

D M Kemeny1, B Vyas, M Vukmanovic-Stejic, M J Thomas, A Noble, L C Loh, B J O'Connor.   

Abstract

COPD is a debilitating and progressive condition in which the airways become irreversibly obstructed and the lungs progressively damaged. Unlike asthma, we know little about the cells that initiate and drive this process. Research has shown that CD8(+) T cells are overrepresented in the lungs of patients with COPD and that they are inversely related to lung function. However, not all CD8(+) T cells are alike and subsets that make IFN-gamma but not IL-4 (Tc1), IL-4 but not IFN-gamma (Tc2) as well as those that make both (Tc0) have been described. This article focuses on the characteristics of CD8(+) T cell subsets and considers their potential contribution to chronic obstructive pulmonary disease (COPD). Kemeny DM, Vyas B, Vukmanovic-Stejic M, Thomas M, Noble A, Loh LC, O'Connor BJ. CD8(+) T cell subsets and chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556167     DOI: 10.1164/ajrccm.160.supplement_1.10

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease.

Authors:  Domenico Spina
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Quantification and evaluation of the role of antielastin autoantibodies in the emphysematous lung.

Authors:  Teck Boon Low; Catherine M Greene; Shane J O'Neill; Noel G McElvaney
Journal:  Pulm Med       Date:  2011-03-31

Review 3.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

4.  Interferon gamma induction of pulmonary emphysema in the adult murine lung.

Authors:  Z Wang; T Zheng; Z Zhu; R J Homer; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

Review 5.  What have transgenic and knockout animals taught us about respiratory disease?

Authors:  Y R Vasquez; D Spina
Journal:  Respir Res       Date:  2000-08-03

6.  Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients.

Authors:  Nailya Kubysheva; Larisa Postnikova; Svetlana Soodaeva; Viкtor Novikov; Tatyana Eliseeva; Ildar Batyrshin; Timur Li; Igor Klimanov; Alexander Chuchalin
Journal:  Dis Markers       Date:  2017-08-07       Impact factor: 3.434

7.  The cellular and molecular determinants of emphysematous destruction in COPD.

Authors:  Masaru Suzuki; Marc A Sze; Joshua D Campbell; John F Brothers; Marc E Lenburg; John E McDonough; W Mark Elliott; Joel D Cooper; Avrum Spira; James C Hogg
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

Review 8.  Roles of Myeloid and Lymphoid Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Ling Ni; Chen Dong
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 9.  Role of macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; Jeffrey L Curtis; Richard Albert
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Mixed T helper cell signatures in chronic rhinosinusitis with and without polyps.

Authors:  Lara Derycke; Stefanie Eyerich; Koen Van Crombruggen; Claudina Pérez-Novo; Gabriele Holtappels; Natalie Deruyck; Philippe Gevaert; Claus Bachert
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.